Walgreens (WBA) earnings Q2 2025

Walgreens (WBA) earnings Q2 2025

A sign for US drugstore chain Walgreens is displayed outside its store in New York City on March 7, 2025. Angela Weiss | AFP | Getty Images Walgreens on Tuesday reported fiscal second-quarter earnings and revenue that topped expectations, as the retail drugstore giant benefits from cost cuts and prepares to go private. The company…

Read More
CMS makes job cuts as RKF Jr. guts HHS

CMS makes job cuts as RKF Jr. guts HHS

An aerial of the Centers for Medicare & Medicaid Services building on March 19, 2025 in Woodlawn, Maryland.  Kayla Bartkowski | Getty Images The Centers for Medicare & Medicaid Services has slashed jobs from its minority health office and other divisions, CNBC has learned, as Robert F. Kennedy Jr. upends the U.S. health department.  During…

Read More
Moderna (MRNA) Q4 earnings 2024

Moderna (MRNA) Q4 earnings 2024

Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to slash costs and demand for its Covid vaccine falls.  It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the rapid decline…

Read More
Biogen (BIIB) earnings Q4 2024

Biogen (BIIB) earnings Q4 2024

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday posted fourth-quarter revenue and profit that topped expectations as its cost cuts showed progress and new products, including its breakthrough Alzheimer’s treatment Leqembi, saw growth.  But the biotech company’s…

Read More
CVS Health (CVS) earnings Q4 2024

CVS Health (CVS) earnings Q4 2024

An exterior view of a CVS pharmacy in Danville, Pennsylvania.  Paul Weaver | Lightrocket | Getty Images CVS Health on Wednesday reported fourth-quarter revenue and profit that topped estimates, even as its troubled insurance business continued to see higher medical costs.  The company also issued a full-year 2025 adjusted earnings outlook of $5.75 to $6…

Read More
Eli Lilly (LLY) earnings Q4 2024

Eli Lilly (LLY) earnings Q4 2024

Eli Lilly on Thursday reported mixed results for the fourth quarter, even as sales of its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soared. The company’s quarterly earnings topped Wall Street estimates, but sales fell just short as Mounjaro saw lower realized prices. Zepbound and Mounjaro have now underperformed expectations for two straight…

Read More
Back To Top